Advertisement

Catecholamines and Endorphins as Neurotransmitters and Neuromodulators

  • George R. Siggins

Abstract

In a meeting devoted to the discussion of synaptic regulation, it seems instructive first to address the issue of what kinds of synaptic messages may be transmitted and what criteria may be developed to define the different types. This task seems particularly timely now because of the burgeoning number of substances found in brain which seem not to strictly fit our preconceived notions of a neurotransmitter. After counting all the peptides, monoamines, amino acids, nucleotides, prostaglandins and steroids that have been advanced as transmitter candidates, I come up with a number exceeding 60. It seems unlikely that such a wide variety of substances would provide only a few chemical messages. Therefore, after developing criteria for neurotransmitters, neuromediators, and modulators, I will provide examples of substances that could satisfy the criteria for these classifications, with special emphasis on norepinephrine (NE), cyclic AMP and the opioid peptides.

Keywords

Purkinje Cell Locus Coeruleus Dorsal Root Ganglion Neuron Cyclic Nucleotide Opioid Peptide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barker, J.L., Gruol, D.L., MacDonald, J.F., and Smith, T.G., Jr. Peptide receptor functions on cultured spinal neurons. In M. Trabucchi and E. Costa (Eds.), Regulation and Function of Neural Peptides Raven Press, 1980 (in press).Google Scholar
  2. 2.
    Barker, J.L., Neale, J.H., Smith, T.G., Jr. and Macdonald, R.L. Opioid peptide modulation of amino-acid responses suggest novel form of neuronal communication. Science 199 (1978) 1451–1453.PubMedCrossRefGoogle Scholar
  3. 3.
    Barker, J.L. and Smith, T.G., Jr. Peptides as neurohormones. Neurosci. Symp 2 (1977) 340–373.Google Scholar
  4. 4.
    Baylor, D.A. and Fuortes, M.G.F. Electrical responses of single cones in the retina of the turtle. J. Physiol . (Lond.) 207 (1970) 77–92.Google Scholar
  5. 5.
    Bloom, F.E. The role of cyclic nucleotides in central synaptic function. Rev. Physiol. Biochem. Pharmacol 74 (1975) 1–103.PubMedGoogle Scholar
  6. 6.
    Bloom, F.E. The role of cyclic nucleotides in central synaptic function. In Advances in Biochemical Pharmacology, Vol. 15, Raven Press, New York, 1976, pp. 273–282.Google Scholar
  7. 7.
    Bloom, F.E. Contrasting principles of synaptic physiology: peptidergic and non-peptidergic neurons. In K. Fuxe, T. H’ökfelt, and R. Luft (Eds.), The Peptidergic Neuron Pergamon Press, New York, 1980, in press.Google Scholar
  8. 8.
    Bloom, F.E. Central noradrenergic neurons: structure-function considerations. In E. Usdin (ed.) Catecholamines: Basic and Clinical Frontiers, Pergamon Press, New York, 1979, pp. 609–618.Google Scholar
  9. 9.
    Bloom, F.E., Siggins, G.R. and Hoffer, B.J. Interpreting the failures to confirm the depression of cerebellar Purkinje cells by cyclic AMP. Science 185 (1974) 627–629.PubMedCrossRefGoogle Scholar
  10. 10.
    Brooks, C. and Eccles, J.C. An electrical hypothesis of central inhibition. Nature 159 (1947) 760–764.PubMedCrossRefGoogle Scholar
  11. 11.
    Brown, B.D.A. and Adams, P.R. Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. Nature 283 (1980) 673–676.PubMedCrossRefGoogle Scholar
  12. 12.
    Burnstock, G., Prosser, C.L., and Holman, M.E. Electrophysiology of smooth muscle. Physiol. Rev. (1963) 482–527.Google Scholar
  13. 13.
    Caesar, R., Edwards, G. and Ruska, H. Architecture and nerve supply of mammalian smooth muscle tissue. J. Biophys. Biochem. Cytol 3 (1957) 867–877.PubMedCrossRefGoogle Scholar
  14. 14.
    Calvillo, O., Henry, J.L. and Neuman, R.S. Effects of morphine and naloxone on dorsal horn neurons in the cat. Canad. J. Physiol. Pharmacol 52 (1974) 1207–1211.CrossRefGoogle Scholar
  15. 15.
    Carpenter, F.G. and Tankersley, J.C. Response of a parasympathetic neuroeffector system to motor nerve stimulation. Am. J. Physiol 196 (1959) 1185–1188.PubMedGoogle Scholar
  16. 16.
    Coombs, J.S., Eccles, J.C. and Fatt, P. The specific ionic conductances and the ionic movements across the motoneuronal membrane that produce the inhibitory post-synaptic potential. J. Physiol 130 (1955) 326–373.PubMedGoogle Scholar
  17. 17.
    Dale, H.H. The action of certain esters and ethers of choline, and their relation to muscarine. J. Pharmacol. Exp. Therap 6 (1906) 163–206.Google Scholar
  18. 18.
    Dale, H.H. Acetylcholine as a chemical transmitter of the effects of nerve impulses. J. Physiol 48 (1914) 3iii-3iv.Google Scholar
  19. 19.
    Dale, H.H. Chemical transmission of the effects of nerve impulses. Brit. Med. J. (1934) 1–20.Google Scholar
  20. 20.
    Davies, J. and Dray, A. Substance P and opiate receptors. Nature 268 (1977) 351–352.PubMedCrossRefGoogle Scholar
  21. 21.
    Dismukes, K. New look at the aminergic nervous system. Nature 269 (1977) 557–558.CrossRefGoogle Scholar
  22. 22.
    Duggan, A.W., Davies, J. and Hall, J.G. Effects of opiate agonists and antagonists on central neurons of the cat. J. Pharmacol. Exp. Ther 196 (1976) 107–120.PubMedGoogle Scholar
  23. 23.
    Dunlap, K. and Fischbach, G.D. Neurotransmitters decrease the calcium component of sensory neurone action potentials. Nature 276 (1978) 837–839.PubMedCrossRefGoogle Scholar
  24. 24.
    Elliott, T.R. The action of adrenaline. J. Physiol. (Lond.) 32 (1904) 401–467.Google Scholar
  25. 25.
    Eccles, J.C. The Physiology of Synapses, Springer-Verlag, Berlin, 1964.CrossRefGoogle Scholar
  26. 26.
    Eccles, J.C., Fatt, P. and Koketsu, K. Cholinergic and inhibitory synapses in a pathway from motor axon collaterals to motoneurones. J. Physiol 216 (1954) 524–562.Google Scholar
  27. 27.
    Eccles, R.M. and Libet, B. Origin and blockade of the synaptic responses of curarized sympathetic ganglia. J. Physiol. (Lond.) 157 (1961) 484–503.Google Scholar
  28. 28.
    Florey, E. Neurotransmitters and modulators in the animal kingdom. Fed. Proc 26 (1967) 1164–1178.PubMedGoogle Scholar
  29. 29.
    Folkow, B. Impulse frequency in sympathetic vasomotor fibres correlated to the release and elimination of the transmitter. Acta Physiol. Scand 25 (1952) 49–76.PubMedCrossRefGoogle Scholar
  30. 30.
    Foote, S.L., Freedman, R. and Oliver, A.P. Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex. Brain Res. 86 (1975) 229–242.PubMedCrossRefGoogle Scholar
  31. 31.
    Frederickson, R.C.A. Enkephalin pentapeptides-a review of current evidence for a physiological role in vertebrate neurotransmission. Life Sci. 21 (1977) 23–40.PubMedCrossRefGoogle Scholar
  32. 32.
    Freedman, R. and Hoffer, B.J. Phenothiazine antagonism of the noradrenergic inhibition of cerebellar Purkinje neurons. J. Neurobiol. 6 (1975) 277–288.PubMedCrossRefGoogle Scholar
  33. 33.
    Freedman, R. and Hoffer, B.J. A quantitative microiontophoretic analysis of the responses of central neurones to noradrenaline: Interactions with cobalt, manganese, verapamil and dichloroisoprenaline. J. Neurobiol 6 (1975) 529–539.CrossRefGoogle Scholar
  34. 34.
    Freedman, R., Hoffer, B.J., Puro, D. and Woodward, D.J. Noradrenaline modulation of the responses of cerebellar Purkinje cells to afferent synaptic activity. Brit. J. Pharmac 57 (1976) 603–605.Google Scholar
  35. 35.
    Freedman, R. and Hoffer, B.J. Interaction of norepinephrine with cerebellar activity evoked by mossy and climbing fibers. Exp. Neurol 55 (1977) 269–288.PubMedCrossRefGoogle Scholar
  36. 36.
    Gahwiler, B.H. Inhibitory action of noradrenaline and cyclic adenosine monophosphate in explants of rat cerebellum. Nature 259 (1976) 483–484.PubMedCrossRefGoogle Scholar
  37. 37.
    Godfraind, J.M. and Pumain, R. Cyclic adenosine monophosphate and norepinephrine: effect on Purkinje cells in rat cerebellar cortex. Science 174 (1971) 1257.Google Scholar
  38. 38.
    Hill, R.G., Mitchell, J.F. and Pepper, C.M. The excitation and depression of hippocampal neurons by iontophoretically applied enkephalins. J. Physiol 272 (1977) 50–51 P.Google Scholar
  39. 39.
    Hiller, J.M., Simon, E.J., Crain, S.H., Peterson, E.R. Opiate receptors in cultures of fetal mouse dorsal root ganglia (DRG) and spinal cord: predominance in DRG neurites. Brain Res. 145 (1978) 396–400.PubMedCrossRefGoogle Scholar
  40. 40.
    Hoffer, B.J., Siggins, G.R., Oliver, A.P. and Bloom, F.E. Activation of the pathway from locus coeruleus to rat cerebellar Purkinje neurons: pharmacological evidence of noradrenergic central inhibition. J. Pharmacol. Exp. Ther 184 (1973) 553–569.PubMedGoogle Scholar
  41. 41.
    Hbkfelt, T. In vitro studies on central and peripheral monoamine neurons at the ultrastructural level. Zeit f. Zellforsch 91 (1968) 1–74.CrossRefGoogle Scholar
  42. 42.
    Horn, J.P. and McAfee, D.A. Norepinephrine inhibits calcium-dependent potentials in rat sympathetic neurons. Science 204 (1979) 1233–1235.PubMedCrossRefGoogle Scholar
  43. 43.
    Jurna, I. Grossman, W., and Theres, C. Inhibition by morphine of repetitive activations of cat spinal motoneurones. Neuropharmacol. 12 (1973) 983–993.CrossRefGoogle Scholar
  44. 44.
    Katz, B. Nerve Muscle and Synapse, McGraw-Hill, Inc., New York, 1966, 193 pp.Google Scholar
  45. 45.
    Klein, M. and Kandel, E.R. Presynaptic modulation of voltage-dependent current: mechanisms for behavioral sensitization in Aplysia californica. Proc. Natl. Acad. Sci. U.S.A 75 (1978) 3512–3516.PubMedCrossRefGoogle Scholar
  46. 46.
    Kobayashi, H. and Libet, B. Generation of slow postsynaptic potentials without increases in ionic conductance. Proc. Natl. Acad. Sci. U.S.A 60 (1968) 1304–1311.PubMedCrossRefGoogle Scholar
  47. 47.
    Koketsu, K. Cholinergic synaptic potentials and the underlying ionic mechanisms. Fed. Proc 28 (1969) 101–112.PubMedGoogle Scholar
  48. 48.
    Korf, J., Roth, R.H. and Aghajanian, G.K. Alterations in turnover and endogenous levels of norepinephrine in cerebral cortex following electrical stimulation and acute axotomy of cerebral noradrenergic pathways. Eur. J. Pharmacol 23 (1973) 276–282.PubMedCrossRefGoogle Scholar
  49. 49.
    Kostopolous, G.K., Limacher, J.J. and Phillis, J.W. Action of various adenine derivatives on cerebellar Purkinje cells. Brain Res. 88 (1975) 162–165.CrossRefGoogle Scholar
  50. 50.
    Krnjevic, K., Pumain, R., and Renaud, L. The mechanisms of excitation of acetylcholine in the cerebral cortex. J. Physiol 215 (1971) 247–268.PubMedGoogle Scholar
  51. 51.
    Lake, N. and Jordan, L.M. Failure to confirm cyclic AMP as second messenger for norepinephrine in rat cerebellum. Science 183 (1974) 663–664.PubMedCrossRefGoogle Scholar
  52. 52.
    Lever, J.D., Graham, J.D.P. and Spriggs, T.L.B. Electron microscopy of nerves in relation to the arteriolar wall. Bibl. Anat 8 (1967) 51–55.Google Scholar
  53. 53.
    Libet, B. Long latent periods and further analysis of slow synaptic responses in sympathetic ganglia. J. Neurophysiol 30 (1967) 494–514.PubMedGoogle Scholar
  54. 54.
    Loewe, O. Uber humorale ubertragbarkeit der herzennervenwirkung. I. Mitteilung. Pflugers Arch. 189 (1962) 238–242.Google Scholar
  55. 55.
    Macdonald, R.L. and Nelson, P.G. Specific opiate-induced depression of transmitter release from dorsal root ganglion cells in culture. Science 199 (1978) 1449–1451.PubMedCrossRefGoogle Scholar
  56. 56.
    Marshall, K.C. and Engberg, I. Reversal potential for noradrenaline-induced hyperpolarization of spinal motoneurons. Science 205 (1979) 422–424.PubMedCrossRefGoogle Scholar
  57. 57.
    Moore, R.Y. and Bloom, F.E. Central catecholamine neuron systems: anatomy and physiology of the norepinephríne and epinephrine systems. Ann. Rev. Neurosci 2 (1979) 113–168.Google Scholar
  58. 58.
    Mudge, A.W., Leeman, S.E. and Fischbach, G.D. Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc. Natl. Acad. Sci. U.S.A 76 (1979) 526–530.PubMedCrossRefGoogle Scholar
  59. 59.
    Nakai, Y. and Takaoír, S. Influence of norepinephrinecontaining neurons derived from the locus coeruleus on lateral geniculate neuronal activities of cats. Brain Res. 71 (1974) 47–60.PubMedCrossRefGoogle Scholar
  60. 60.
    Nakajíma, S. and Takahashi, K. Post-tetanic hyperpolarization and electrogenic Na pump in stretch receptor neurone of crayfish. J. Physiol 187 (1967) 105–127.Google Scholar
  61. 61.
    Nathanson, J. Cyclic nucleotides and nervous system function. Physiol. Rev 57 (1977) 157–256.PubMedGoogle Scholar
  62. 62.
    Nathanson, J., Freedman, R. and Hoffer, B.J. Lanthanum inhibits brain adenylate cyclase and blocks noradrenergic depression of Purkinje cell discharge independent of calcium. Nature 261 (1976) 330–331.PubMedCrossRefGoogle Scholar
  63. 63.
    Nicoll, R.A., Siggins, G.R., Ling, N., Bloom, F.E. and Guillemin, R. Neuronal actions of endorphins and enkephalins among brain region: A comparative microiontophoretíc study. Proc. Natl. Acad. Sci. U.S.A 74 (1977) 2584–2588.PubMedCrossRefGoogle Scholar
  64. 64.
    Nishi, S. and Koketsu, K. Origin of ganglionic inhibitory postsynaptic potentials. Life. Sci 6 (1967) 2049–2055.PubMedCrossRefGoogle Scholar
  65. 65.
    Nishi, S. and Koketsu, K. Early and late discharges of amphibian sympathetic ganglion cells. J. Neurophysiol 31 (1968) 717–728.PubMedGoogle Scholar
  66. 66.
    North, R.A. Effects of morphine on myenteric plexus neurones. Neuropharmacol. 15 (1976) 1–9.CrossRefGoogle Scholar
  67. 67.
    North, R.A. and Henderson, G. Action of morphine on guinea pig myenteric plexus and mouse vas deferens studied by intracellular recording. Life Sci. 17 (1975) 63–66.PubMedCrossRefGoogle Scholar
  68. 68.
    North, R.A., Katayama, K., and Williams, J.T. On the mechanism and site of action of enkephalin on single myenteric neurons. Brain Res. 165 (1979) 67–77.PubMedCrossRefGoogle Scholar
  69. 69.
    North, R.A. and Williams, J.T. Enkephalin inhibits firing of myenteric neurones. Nature (London) 264 (1976) 460–461.CrossRefGoogle Scholar
  70. 70.
    North, R.A. and Williams, J.T. Actions of enkephalin on myenteric neurons. Fed. Proc 36 (1977) 965.Google Scholar
  71. 71.
    Pellmar, T.C. and Carpenter, D.O. Voltage-dependent calcium current induced by serotonin. Nature 277 (1979) 483–484.PubMedCrossRefGoogle Scholar
  72. 72.
    Pepper, C.M. and Henderson, G. Opiates and opioíd peptides hyperpolarize locus coeruleus neurons in vitro. Science 209 (1980) 394–396.PubMedCrossRefGoogle Scholar
  73. 73.
    Phillis, J.W., Kostopoulos, G.K. and Limacher, J.J. Depression of corticospinal cells by various purines and pyrimidines. Can. J. Physiol. Pharmacol 52 (1974) 1227–1229.Google Scholar
  74. 74.
    Rall, T.W. Role of adenosine 3’,5’-nonophosphate (cyclic AMP) in actions of catecholamines. Pharmacol. Rev 24 (1972) 399–409.PubMedGoogle Scholar
  75. 75.
    Renaud, L.P., Blume, H.W., Pittman, Q.J., Lamour, Y. and Tan, A.T. Thyrotropin-releasing hormone selectivity depresses glutamate excitation of cerebral cortical neurons. Science 205 (1979) 1275–1277.PubMedCrossRefGoogle Scholar
  76. 76.
    Richardson, K.C. Electronmicroscopic observation of Auerbach’s plexus in the rabbit, with special reference to the problem of snooth muscle innervation. Am. J. Anat 103 (1958) 99–135.PubMedCrossRefGoogle Scholar
  77. 77.
    Segal, M. Lithium and the monoamine neurotransmitters in the rat híppocampus. Nature 250 (1974) 71–73.PubMedCrossRefGoogle Scholar
  78. 78.
    Segal, M. Brain stem afferents to the rat medial septum. J. Physiol 261 (1976) 617–631.PubMedGoogle Scholar
  79. 79.
    Segal, M. and Bloom, F.E. The action of norepinephrine in the rat híppocampus. II. Activation of the input pathway. Brain Res. 72 (1974) 99–114.PubMedCrossRefGoogle Scholar
  80. 80.
    Segal, M. and Bloom, F.E. The action of norepinephrine in the rat híppocampus. IV. The effects of locus coeruleus stimulation on evoked hippocampal unit activity. Brain Res. 107 (1976) 513–525.PubMedCrossRefGoogle Scholar
  81. 81.
    Shoemaker, W.J., Balentin, L.T., Síggins, G.R., Hoffer, B.J., Henriksen, S.J. and Bloom, F.E. Characteristics of the release of cyclic adenosine 3’,5’-monophosphate from micropipetts by microíontophoresis. J. Cyclic Nucleotide Res 1 (1975) 97–106.PubMedGoogle Scholar
  82. 82.
    Siggíns, G.R. The electrophysiological effects of cyclic nucleotides on excitable tissue. In H. Cramer and J. Schultz (Eds), Cyclic Nucleotides: Mechanisms of Action, John Wiley and Sons, Ltd., London-New York, 1977.Google Scholar
  83. 83.
    Siggins, G.R. Electrophysiological assessment of mono-nucleotides and nucleosides as first and second messengers in the nervous system. In A. Karlin, V.M. Tennyson and H.J. Vogel (Eds.), Neuronal Information Transfer, Academic Press, New York, 1978, p. 339.Google Scholar
  84. 84.
    Siggíns, G.R. Cyclic nucleotides: regulation of cellular excitability. In J. Nathanson and J. Kebabían (Eds.), Handbook of Experimental Pharmacology, Vol. Cyclic Nucleotides Springer-Verlag, Berlin, in press.Google Scholar
  85. 85.
    Siggins, G.R. and Henriksen, S.J. Analogues of cyclic adenosine monophosphate: correlation of inhibition of purkinje neurons with protein kinase activation. Science 189 (1975) 559–561.PubMedCrossRefGoogle Scholar
  86. 86.
    Síggins, G.R., Hoffer, B.J. and Bloom, F.E. Cyclic adenosine monophosphate: possible mediator for norepinephrine effects on cerebellar purkinje cells. Science 165 (1969) 1018–1020.PubMedCrossRefGoogle Scholar
  87. 87.
    Siggins, G.R., Hoffer, B.J. and Bloom, F.E. Studies on norepínephrine-containing afferents to Purkínje cells of rat cerebellum: III. Sensitivity evidence for mediation of norephrine effects by cyclic 3’,5’ adenosine monophosphate. Brain Res. 25 (1971) 535–553.PubMedCrossRefGoogle Scholar
  88. 88.
    Siggins, G.R., Oliver A.P., Hoffer, B.J. and Bloom, F.E. Cyclic adenosine monophosphate and norepinephrine: effects on transmembrane properties of cerebellar Purkinje cells. Science 171 (1971) 192.PubMedCrossRefGoogle Scholar
  89. 89.
    Siggins, G.R., Hoffer, B.J., Oliver, A.P. and Bloom, F.E. Cyclic AMP mediation of norepinephrine synaptic inhibition in rat cerebellar cortex: A unique class of synaptic responses. Nature 233 (1971) 481–483.PubMedCrossRefGoogle Scholar
  90. 90.
    Siggins, G.R., Henriksen, S.J. and Landis, S.C. Electrophysiology of Purkinje neurons in the weaver mouse: iontophoresis of neurotransmitters and cyclic nucleotides, and stimulation of the nucleus locus coeruleus. Brain Res. 114 (1976) 53–65.PubMedCrossRefGoogle Scholar
  91. 91.
    Siggins, G.R., Zieglgansberger, W., French, E., Ling, N. and Bloom, F. Opiates and opioíd peptides may excite hippocampal (HPC) neurons by inhibiting adjacent inhibitory interneurons. Neurosci. Abstr. 4 (1978) 414.Google Scholar
  92. 92.
    Speden, R. Electrical activity of single smooth muscle cells of the mesenteric artery produced by splanchnic nerve stimulation in the guinea pig. Nature 202 (1964) 193–194.PubMedCrossRefGoogle Scholar
  93. 93.
    Stone, T.W. and Taylor, D.A. Microiontophoretic studies of the effects of cyclic nucleotides on excitability of neurons in the rat cerebral cortex. J. Physiol 266 (1977) 523–543.PubMedGoogle Scholar
  94. 94.
    Sutherland, E.W., Oye, I., and Butcher, R.W. The action of epinephrine and the role of the adenylcyclase system in hormone action. Rec. Progr. Hormone Res 21 (1965) 523–642.Google Scholar
  95. 95.
    Thomas, R.C. Electrogenic sodium pump in nerve and muscle cells. Physiol. Rev 52 (1972) 563–594.PubMedGoogle Scholar
  96. 96.
    Weight, F.F. and Padjen, A. Slow synaptic inhibition: evidence for synaptic inactivation of sodium conductance in sympathetic ganglion cells. Brain Res. 55 (1973) 219–224.PubMedCrossRefGoogle Scholar
  97. 97.
    Weight, F.F. and Padjen, A. Acetylcholine and slow synaptic inhibition in frog sympathetic ganglion cells. Brain Res. 55 (1973) 225–228.PubMedCrossRefGoogle Scholar
  98. 98.
    Werman, R. Criteria for identification of a central nervous system transmitter. Comp. Biochem. Physiol 18 (1966) 745–766PubMedCrossRefGoogle Scholar
  99. 99.
    Yarbrough, G.G. TRH potentiates excitatory actions of acetylcholine on cerebral cortical neurons. Nature 263 (1976) 523–524.PubMedCrossRefGoogle Scholar
  100. 100.
    Zieglgänsberger, W. and Bayerl, J. The mechanisms of inhibition of neuronal activity by opiates in the spinal cord of cat. Brain Res. 115 (1976) 111–128.PubMedCrossRefGoogle Scholar
  101. 101.
    Zieglgänsberger, W., French, E.D., Siggins, G.R. and Bloom, F.E. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science 205 (1979) 415–417.PubMedCrossRefGoogle Scholar
  102. 102.
    Zieglgansberger, W., and Fry, J.P. Actions of enkephalin on cortical and striatal neurones of naive and morphine/tolerant dependent rats. In H.W. Kosterlitz (Ed) Opiates and Endogenous Opioid Peptides, Elsevier/North-Holland, Biomedical Press, Amsterdam, 1976, pp. 213–238.Google Scholar
  103. 103.
    Zieglgansberger, W. and Fry, J.P. Actions of opioids on single neurons. In A. Herz (Ed), Development in Opiate Research, Marcel Dekker, New York, 1978.Google Scholar
  104. 104.
    Zieglgansberger, W. and Puil, E.A. Action of glutamic acid on spinal neurones. Exp. Brain Res 17 (1972) 35–49.Google Scholar
  105. 105.
    Zieglgansberger, W. and Reiter, C.H. A cholnergic mechanism in the spinal cord of cats. Neuropharmacol. 13 (1974) 519–527.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • George R. Siggins
    • 1
  1. 1.Arthur V. Davis Center for Behavioral NeurobiologyThe Salk InstituteLa JollaUSA

Personalised recommendations